LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Interview with… Krijn de Nood, Co-Founder & CEO at Meatable

12/05/2021
INTERVIEW

About Krijn de Nood

Krijn de Nood is CEO and Co-Founder of Meatable, guiding the company’s strategic direction. He holds a Master’s degree in Economics and Finance, and a Bachelor’s degree in Philosophy. Before founding Meatable, he worked for six years at management consulting firm McKinsey & Company, where he cultivated his expertise in strategy development and operations. Through Meatable, Krijn is realizing his ambition to contribute to solving several of the biggest challenges of his generation..

Interview with... Krijn de Nood, Co-Founder & CEO at Meatable

1) What inspired the foundation of Meatable?
During an Erasmus philosophy course in Barcelona, I came across the philosophy of animal rights activist Peter Singer and realised that there was a huge ethical problem - around slaughtering animals for food- about which little was being done. This insight stayed with me for years. After leaving McKinsey I planned to take a year off, but I quickly met Daan Luining and Mark Kotter. Daan had a great idea, Mark had a distinctive technology and I had the commercial insight to do something with the ethical problem. Together we founded Meatable. Industrial meat farming is unsustainable. To turn around climate change, the prevent future pandemics, to reduce animal suffering, to feed 10bn people and to optimize water use, we need to turn to alternative protein solutions. I am motivated by being part of that change.

2) What potential do you see in demand for cultivated meat?
The product billions of people around the world love, without any of the drawbacks! It is amazing to see how people’s stance towards cultivated meat has changed in the past few years, understanding that the current way we are producing our meat is not sustainable. And more and more people are getting excited about the solution cultivated meat can bring to their plates.

3) What are your plans for growth?
We want to make a significant contribution to solving the issues, as listed in the first question, so you can imagine our ambitions are BIG. Looking at climate change in particular, and the need and urgency felt globally to make a change, our meat needs to at least match the prices for conventional meat. But before our products will hit the stores, we need to reach several milestones. After successfully completing our very first pork sausage, our prototype, end of 2020 and reaching a funding total of more than $60M to date (including a grant from the European Union, funded by the European commission in 2019), we are now working hard to have our small-scale production facility ready as soon as possible. After that, we want to have our products available in stores by 2025.

4) How do you see Meatable being able to transform the meat industry's impact on climate change and animal welfare?
Although our meat is being seen as an alternative protein, we see ourselves also being part of the meat industry as a whole. We are working on a new, sustainable way to produce meat, because we believe there is room for a more animal and planet friendly way. People enjoy eating meat and it is an important source of protein. It’s a trillion dollar industry that continues to grow, 2% year on year until 2050 is the prediction. We believe there is room for (much) more sustainably produced meat and we are convinced the market for sustainably produced meat, plus traditional, cultured meat or otherwise, will continue to grow. With our product, people will be able to enjoy real meat, without any of the drawbacks associated with industrial farming. No animals are killed, fewer emissions are released, and significantly less land and water are required. Because of this, we feel confident that people will also want to include our meat in their diet, as soon as they had the chance to experience it..

Interview with Meatable


Download
2021_05_G_O_Interview with… MeatableDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.